Outlook Therapeutics, Inc. — Form D

Outlook Therapeutics, Inc. of ISELIN, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2024-04-16. The offering totals $13.3M, of which $5.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (45)

Showing 25 of 45 people.

NameRoleLocation
C. Russell TrenaryDirectorIselin, NJ
Jeff Russell EvansonExecutive OfficerIselin, NJ
C. Russell TrenaryExecutive OfficerIselin, NJ
Lawrence A KenyonDirectorIselin, NJ
Lawrence A KenyonExecutive OfficerIselin, NJ
Jeff A EvansonExecutive OfficerIselin, NJ
Faisal G SukhtianDirectorIselin, NJ
Julia A HallerDirectorIselin, NJ
Gerd G AuffarthDirectorIselin, NJ
Yezan H HaddadinDirectorIselin, NJ
Randy H ThurmanDirectorIselin, NJ
Julian G GangolliDirectorIselin, NJ
Andong G HuangDirectorIselin, NJ
Kurt J HilzingerDirectorIselin, NJ
Pankaj MohanDirectorPrinceton, NJ
Pankaj MohanExecutive OfficerPrinceton, NJ
Julian GangolliRelated PersonIselin, NJ
Todd BradyDirectorAtlanta, GA
Randy ThurmanDirectorMonmouth Junction, NJ
Yezan HaddadinDirectorIselin, NJ
Yezan HaddadinRelated PersonIselin, NJ
Jeff G EvansonExecutive OfficerMonmouth Junction, NJ
Terry G DagnonExecutive OfficerMonmouth Junction, NJ
Donald GriffithDirectorPrinceton, NJ
Donald GriffithExecutive OfficerPrinceton, NJ

Other filings by this issuer (12)

FiledFormOfferingSold
2026-05-07D$5.0M
2025-01-27D$32.0M
2024-03-29D$159.0M$60.0M
2023-01-06D$1.0M$1.0M
2023-01-06D$31.8M$31.8M
2021-02-12D$4.0M$4.0M
2020-06-09D$16.0M$16.0M
2020-03-11D$8.0M$8.0M
2017-09-25D$40.1M$3.3M
2015-12-23D$50.0M$6.3M
2015-10-13D$14.5M$14.5M
2015-08-10D$31.1M$31.1M

More